RecruitingNot ApplicableNCT06390358

Effects of Remote Cardiac Ischemic Preconditioning

Acute and Chronic Effects of Tefillin Use on Remote Cardiac Ischemic Preconditioning


Sponsor

Jack Rubinstein

Enrollment

24 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A heart attack occurs when blood flow is disrupted to the heart and is related to both the blockage and flow restoration (reperfusion injury). An occlusion during a heart attack can be cleared (mostly via stents), but there are no methods to decrease reperfusion injury even though animal studies have found that "preconditioning" has powerful protective effects. Through the observation of Jewish men wearing tefillin the investigators have discovered a method of bringing preconditioning to patients at risk for heart attacks. This study will focus on women as the majority of people who wear tefillin (and have been studied) are men.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria1

  • Females over 18 years of age

Exclusion Criteria1

  • Current medication use for medical condition or active medical condition

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTefillin

Wrapping of arm


Locations(1)

University of Cincinnati

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06390358